Marlene Gyldmark

Cost-Effectiveness of Erlotinib versus Docetaxel for Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer in the United Kingdom

G Lewis, Michael Peake, R Aultman et al. · Journal of International Medical Research · 2010 · 43 citations

Demand for health care in Denmark: results of a national sample survey using contingent valuation

Marlene Gyldmark, Gwendolyn C. Morrison · Social Science & Medicine · 2001 · 34 citations

Economics, National Sample Survey, Healthcare Value +8

The Danish Approach to Standards For Economic Evaluation Methodologies

Anita Alban, Marlene Gyldmark, Arne Vesth Pedersen et al. · PharmacoEconomics · 1997 · 31 citations

Economics, Danish Approach, Applied Economics +6

Effect of Influenza Treatment with Oseltamivir on Health Outcome and Costs in Otherwise Healthy Children

Keith S. Reisinger, Gerald R. Greene, R Aultman et al. · Clinical Drug Investigation · 2004 · 24 citations

Otherwise Healthy Children, Health Economics, Health Outcome +8

Post-Exposure Influenza Prophylaxis with Oseltamivir

Beate Sander, Frederick G. Hayden, Marlene Gyldmark et al. · PharmacoEconomics · 2006 · 21 citations · Full text

Vaccination, Post-exposure Influenza Prophylaxis, Influenza Vaccine +3